Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study
- 1 December 2000
- journal article
- conference paper
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (12), 1395-1409
- https://doi.org/10.1016/s0149-2918(00)83039-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pioglitazone liver enzyme profile is similar to placebo in US controlled clinical trialsDiabetes Research and Clinical Practice, 2000
- Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes MellitusJAMA, 2000
- Pharmacologic Therapy for Type 2 Diabetes MellitusAnnals of Internal Medicine, 1999
- RosiglitazoneDrugs, 1999
- Mechanisms and clinical effects of thiazolidinedionesExpert Opinion on Investigational Drugs, 1997
- Pioglitazone (AD-4833) Ameliorates Insulin Resistance in Patients with NIDDMThe Tohoku Journal of Experimental Medicine, 1997
- Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeysDiabetes, 1994
- The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patientsMetabolism, 1993
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985